CAS No. |
2378114-72-6 |
中文名称 |
乙酸盐:13-((1H-吲哚-3-基)甲基)-19-(2-氨基-3-(萘-2-基)丙酰胺基)-N-(1-氨基-3-羟基-1-氧代丁烷-2-基)-10-(4-氨基丁基)-16-(4-羟基苄基)-7-异丙基-6,9,12,15,18-五氧代-1,2-二硫杂-5,8,11,14,17-五氮杂环二十烷-4-甲酰胺 |
英文名称 |
13-((1H-indol-3-yl)methyl)-19-(2-amino-3-(naphthalen-2-yl)propanamido)-N-(1-amino-3-hydroxy-1-oxobutan-2-yl)-10-(4-aminobutyl)-16-(4-hydroxybenzyl)-7-isopropyl-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carboxamide acetate |
别名 |
DC13-116 | ITM-014 | BN-52030 | Somatuline LP | P1088 | Somatuline | CS-0113779 | Lanreotide (acetate) | acetic acid;(4R,7S,10S,13R,16S,19R)-10-(4-aminobutyl)-N-[(2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl]-19-[[(2R)-2-amino-3-naphthalen-2-ylpropanoyl]amino |
标准英文名 |
13-((1H-indol-3-yl)methyl)-19-(2-amino-3-(naphthalen-2-yl)propanamido)-N-(1-amino-3-hydroxy-1-oxobutan-2-yl)-10-(4-aminobutyl)-16-(4-hydroxybenzyl)-7-isopropyl-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carboxamide acetate |
MDL No. |
MFCD00873576 |
分子式 |
C56H73N11O12S2 |
分子量 |
1156.40
|
精确分子量 |
1155.49
|
SMILES |
CC(=O)O.CC(C)C1NC(=O)C(CCCCN)NC(=O)C(CC2=CNC3=CC=CC=C23)NC(=O)C(CC2=CC=C(O)C=C2)NC(=O)C(NC(=O)C(N)CC2=CC3=CC=CC=C3C=C2)CSSCC(C(=O)NC(C(N)=O)C(C)O)NC1=O |
标准SMILES |
CC(O)=O.CC(O)C(NC(=O)C1CSSCC(NC(=O)C(N)CC2=CC3=CC=CC=C3C=C2)C(=O)NC(CC2=CC=C(O)C=C2)C(=O)NC(CC2=CNC3=CC=CC=C23)C(=O)NC(CCCCN)C(=O)NC(C(C)C)C(=O)N1)C(N)=O |
用途 |
Lanreotide acetate is a somatostatin analog used as a physiological inhibitor of growth hormone (GH) secretion; it exhibits antitumor activity by inhibiting proliferation and hormone release in GH-secreting pituitary adenoma cells in vitro; it enhances radiation-induced apoptosis in GH3 cells; it reduces colony formation of GH3 cells in a dose-dependent manner; in vivo, it inhibits tumor growth in GH3 tumor-bearing nude mice following subcutaneous administration. |
InChIKey |
DEXPIBGCLCPUHE-UHFFFAOYSA-N |